CEFOTAXIME SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Cefotaxime Sodium patents expire, and when can generic versions of Cefotaxime Sodium launch?
Cefotaxime Sodium is a drug marketed by Aurobindo Pharma, Aurobindo Pharma Ltd, Cephazone Pharma, Hospira, Hospira Inc, Lupin, and Wockhardt. and is included in nine NDAs.
The generic ingredient in CEFOTAXIME SODIUM is cefotaxime sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cefotaxime sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFOTAXIME SODIUM?
- What are the global sales for CEFOTAXIME SODIUM?
- What is Average Wholesale Price for CEFOTAXIME SODIUM?
Summary for CEFOTAXIME SODIUM
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 126 |
| Clinical Trials: | 8 |
| Patent Applications: | 2,458 |
| DailyMed Link: | CEFOTAXIME SODIUM at DailyMed |
Recent Clinical Trials for CEFOTAXIME SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fayoum University Hospital | Phase 4 |
| Federal University of São Paulo | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Medical Subject Heading (MeSH) Categories for CEFOTAXIME SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for CEFOTAXIME SODIUM
US Patents and Regulatory Information for CEFOTAXIME SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065517-002 | Nov 6, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wockhardt | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065197-002 | Jun 20, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 203132-002 | Feb 19, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aurobindo Pharma Ltd | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065516-001 | Nov 6, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira Inc | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065292-001 | Aug 10, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira Inc | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065290-002 | Aug 11, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lupin | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065124-001 | Sep 24, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
